The RISE (Rare Disease) Selling Framework consists of the following:
Readiness, Inspiration, Signals and Energizer.
Each element is designed to elevate the skills of experienced biopharma representatives who enter the rare disease sector with the purpose of impacting lives. RISE is a transformational strategy for transformational therapeutics. RISE is designed to RISE above the traditional pharmaceutical methods, enabling organizations to become a rare voice for rare disease patients. A successful rare disease representative has the expertise to inspire others to help others in need. Rare disease patients are in search of solutions. A successful rare disease representative can be the voice that leads to solutions for suffering patients. RISE, it’s a new day. Are you ready?
The RISE (Rare Disease) Leadership Framework
Just as engaging external stakeholders in the rare disease sector differs from the non-rare disease sector, so does coaching and leading teams within this space. That is the nature of this book. This book is a companion to the first book we published: The RISE (Rare Disease) Selling Framework, designed for individual contributors of a rare disease commercial team.
The foundation of this book, The RISE (Rare Disease) Leadership Framework, is the following:
- Decades of life sciences commercial research and experience, including field, leadership, operations, and learning & development within the life sciences sector.
- Countless collaboration events and interviews with second-line and first-line rare disease leaders, including learning & development business partners.
- The first book ever published specifically for individual field contributors for a rare disease commercial organization. That book – The RISE (Rare Disease) Selling Framework, is a companion to this book, The RISE (Rare Disease) Leadership Framework.
Testimonial: “Peter’s experience and passion in Learning and Development, leading, coaching and selling in the rare disease sector, is a unique combination that can bring immense value to your organization.” —Mart Byford, Rare Disease leader and Learning & Development business partner.